Navidea Biopharmaceuticals Announces Positive Results of First Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis Oct 29, 2019
Navidea Biopharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference Sep 6, 2019
Navidea Biopharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business Update Aug 1, 2019
Navidea Biopharmaceuticals Announces SNMMI Press Release and Recognition of Phase 1/2 Study Results Jun 24, 2019
Navidea Biopharmaceuticals Announces Day and Time of SNMMI Presentation of Phase 1/2 Study Results and Enrollment Update on its Phase 2B Study Jun 17, 2019
